D-serine regulation: A possible therapeutic approach for central nervous diseases and chronic pain

Mini-Reviews in Medicinal Chemistry

Volumn 9, Issue 7, 2009, Pages 813-819

  Sethuraman, R ^a   Lee, T L ^a   Tachibana, Shinro ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Amino acid transporters; Chronic pain; CNS diseases; D amino acid oxidase; D Serine; NMDA receptors; Serine racemase

Indexed keywords

5 CHLOROBENZO[D]ISOXAZOL 3 OL; 5 METHYL 3 PYRAZOLECARBOXYLIC ACID; 5,7 DICHLOROKYNURENIC ACID; AMINOOXYACETIC ACID; CYCLOSERINE; DEXTRO AMINO ACID OXIDASE; DEXTRO SERINE; FLUOROCITRIC ACID; GLYCINE; N [3 (4' FLUOROPHENYL) 3 (4' PHENYLPHENOXY)PROPYL]SARCOSINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; OXIDOREDUCTASE INHIBITOR; PHENCYCLIDINE; SARCOSINE; UNCLASSIFIED DRUG; SERINE;

ALZHEIMER DISEASE; AMINO ACID ANALYSIS; AMINO ACID BRAIN LEVEL; AMINO ACID METABOLISM; AMINO ACID SYNTHESIS; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIPOLAR DISORDER; CAPILLARY ELECTROPHORESIS; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CHRONIC PAIN; COGNITIVE DEFECT; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NEUROMODULATION; NOCICEPTION; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; SCHIZOPHRENIA; SPINOCEREBELLAR DEGENERATION; UNSPECIFIED SIDE EFFECT; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CHRONIC DISEASE; METABOLISM; PAIN; REVIEW; STEREOISOMERISM;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; CHRONIC DISEASE; HUMANS; PAIN; SERINE; STEREOISOMERISM;

EID: 68849123896     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955709788452630     Document Type: Article

References (85)

1. Mothet, J.P.; Parent, A.T.; Wolosker, H.; Brady,Jr., R.O.; Linden, D.J.; Ferris, C.D.; Rogawski, M.A.; Snyder, S.H. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. U.S.A., 2000, 97, 4926-31.
2. Oliet, S.H.; Mothet, J.P. Molecular determinants of D-serinemediated gliotransmission: from release to function Glia, 2006, 54, 726-37.
3. Sethuraman, R.; Krishnamoorthy, M.G.; Lee, T.L.; Liu, E.H.C.; Siau, C.; Nishimura, W.; Sakai, M.; Minami, T.; Tachibana, S. Simultaneous analysis of D- and L-serine in cerebrospinal fluid by use of HPLC. Clin. Chem., 2007, 53, 1489-94.
4. Guo, J.D.; Wang, H.; Zhang, Y.Q.; Zhao, Z.Q. distinct effects of Dserine on spinal nociceptive responses in normal and carrageenan-injected rats. Biochem. Biophys. Res. Commun., 2006, 343, 401-6.
5. Yoshikawa, M.; Ito, K.; Maeda, M.; Akahori, K.; Takahashi, S.; Jin, X.L.; Matsuda, M.; Suzuki, T.; Oka, T.; Kobayashi, H.; Hashimoto, A. Activation of supraspinal NMDA receptors by both Dserine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats. Eur. J. Pharmacol., 2007, 565, 89-97.
6. Burnet, P.W.; Hutchinson, L.; von Hesling, M.; Gilbert, E.J.; Brandon, N.J.; Rutter, A.R.; Hutson, P.H.; Harrison, P.J. Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia. Schizophr. Res., 2008, 102, 283-94.
7. Hamase, K.; Morikawa, A.; Zaitsu, K. D-amino acids in mammals and their diagnostic value. J. Chromatogr. B., 2002, 781, 73-91.
8. Fukushima, T.; Kawai, J.; Imai, K.; Toyo'oka, T. Simultaneous determination of D- and L-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection. Biomed. Chromatogr., 2004, 18, 813-9.
9. Koval, D.; Jiraskova, J.; Strisovsky, K.; Konvalinka, J.; Kasicka, V. Capillary electrophoresis method for determination of D-serine and its application for monitoring of serine racemase activity. Electrophoresis, 2006, 27, 2558-66.
10. Hashimoto, A.; Nishikawa, T.; Oka, T.; Takahashi, K.; Hayashi, T. Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tert.-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde. J. Chromatogr., 1992, 582, 41-8.
11. Bruckner, H.S. Gas chromatographic quantification of free D-amino acids in higher vertebrates. Biomed. Chromatogr., 2005, 6, 466-73.
12. Morikawa, A.; Hamase, K.; Inoue, T.; Konno, R.; Niwa, A.; Zaitsu, K. Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino acid oxidase activity. J. Chromatogr. B., 2001, 757, 119-25.
13. Hamase, K.; Homma, H.; Takigawa, Y.; Fukushima, T.; Santa, T.; Imai, K. Determination of free D-aspartic acid, D-serine and Dalanine in the brain of mutant mice lacking D-amino acid oxidase activity. Biochem. Biophys. Acta., 1997, 1334, 214-22.
14. Sethuraman, R.; Lee, T.L.; Tachibana, S. Simple quantitative HPLC method for measuring physiologic amino acid in cerebrospinal fluid without pre-treatment. Clin. Chem., 2004, 50, 665-9.
15. Fuchs, S.A.; de Sain-van der Velden, M.G.; de Barse, M.M.; Roeleveld, M.W.; Hendriks, M.; Dorland, L.; Klomp, L.W.; Berger, R.; de Koning, T.J. Two mass-spectrometric techniques for quantifying serine enantiomers and glycine in cerebrospinal fluid: potential confounders and age-dependent ranges. Clin. Chem., 2008, 54, 1443-50.
16. Hashimoto, A.; Oka, T.; Nishikawa, T. Anatomical distribution and postnatal changes in endogenous free D-aspartate and D-serine in rat brain and periphery. Eur. J. Neurosci., 1995, 7, 1657-63.
17. Schell, M.J.; Molliver, M.E.; Snyder, S.H. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamatestimulated release. Proc. Natl. Acad. Sci. U.S.A., 1995, 92, 3948-52.
18. Schell, M.J.; Brady, R.O. Jr.; Molliver, M.E.; Snyder, SH. D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. J. Neurosci., 1997, 17, 1604-15.
19. Wolosker, H.; Blackshaw, S.; Snyder, S.H. Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-Daspartate neurotransmission. Proc. Natl. Acad. Sci. U.S.A., 1999, 96, 13409-14.
20. Xia, M.; Liu, Y.; Figueroa, D.J.; Chiu, C.S.; Wei, N.; Lawlor, A.M.; Lu, P.; Sur, C.; Koblan, KS.; Connolly, TM. Characterization and localization of a human serine racemase. Mol. Brain Res., 2004, 125, 96-104.
21. Williams, S.M.; Diaz, C.M.; Macnab, L.T.; Sullivan, R.K.; Pow, D.V. Immunocytochemical analysis of D-serine distribution in the mammalian brain reveals novel anatomical compartmentalizations in glia and neurons. Glia, 2006, 53, 401-11.
22. Wu, S.Z.; Bodles, A.M.; Porter, M.M.; Griffin, W.S.; Basile, A.S.; Barger, S.W. Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide. J. Neuroinflammation, 2004, 1, 2.
23. Kartvelishvily, E.; Shleper, M.; Balan, L.; Dumin, E.; Wolosker, H. Neuron-derived D-serine release provides a novel means to activate Nmethyl-D-aspartate receptors. J. Biol. Chem., 2006, 281, 14151-62.
24. Yasuda, E.; Ma, N.; Semba, R. Immunohistochemical evidences for localization and production of D-serine in some neurons in the rat brain. Neurosci. Lett., 2001, 299(1/2), 162-4.
25. De Miranda, J.; Panizzutti, R.; Foltyn, V.N.; Wolosker, H. Immunohistochemical evidences for localization and production of D-serine in some neurons in the rat brain. Proc. Natl. Acad. Sci. U.S.A., 2002, 99, 14542-62.
26. Cook, S.P.; Galve-Roperh, I.; Martinez del Pozo, A.; Rodriguez-Crespo, I.J. Direct calcium binding results in activation of brain serine racemase. Biol. Chem., 2002, 277, 27782-92.
27. Dunlop, D.S.; Neidle, A. Regulation of serine racemase activity by amino acids. Mol. Brain. Res., 2005, 133, 208-14.
28. Mothet, J.P.; Pollegioni, L.; Ouanounou, G.; Martineau, M.; Fossier, P.; Baux, G. Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine. Proc. Natl. Acad. Sci. USA, 2005, 102, 5606-11.
29. Hashimoto, A.; Oka, T.; Nishikawa, T. Extracellular concentration of endogenous free D-serine in the rat brain as revealed by in vivo microdialysis. Neuroscience, 1995, 66, 635-43.
30. Matsuo, H.; Kanai, Y.; Tokunaga, M.; Nakata, T.; Chairoungdua, A.; Ishimine, H.; Tsukada, S.; Ooigawa, H.; Nawashiro, H.; Kobayashi, Y.; Fukuda, J.; Endou, H. High affinity D- and L-serine transporter Asc-1: cloning and dendritic localization in the rat cerebral and cerebellar cortices. Neurosci. Lett., 2004, 358, 123-6.
31. Ribeiro, C.S.; Reis, M.; Panizzutti, R.; De Miranda, J.; Wolosker, H. Glial transport of the neuromodulator D-serine. Brain Res., 2002, 929, 202-9.
32. Javitt, D.C.; Balla, A.; Sershen, H. A novel alanine-insensitive Dserine transporter in rat brain synaptosomal membranes. Brain Res., 2002, 941(1/2), 146-9.
33. Rutter, A.R.; Fradley, R.L.; Garrett, E.M.; Chapman, K.L.; Lawrence, J.M.; Rosahl, T.W.; Patel, S. Evidence from gene knockout studies implicates Asc-1 as the primary transporter mediating D-serine reuptake in the mouse CNS. Eur. J. Neurosci., 2007, 25, 1757-66.
34. Martineau, M.; Baux, G.; Mothet, J.P. D-serine signalling in the brain: friend and foe. Trends Neurosci., 2006, 29, 481-91.
35. Moreno, S.; Nardacci, R.; Cimini, A.; Ceru, M.P. Immunocytochemical localization of D-amino acid oxidase in rat brain. J. Neurocytol., 1999, 28, 169-85.
36. Urai, Y.; Jinnouchi, O.; Kwak, K.T.; Suzue, A.; Nagahiro, S.; Fukui, K. Gene expression of D-amino acid oxidase in cultured rat astrocytes: regional and cell type specific expression. Neurosci. Lett., 2002, 324, 101-4.
37. Hamase, K.; Konno, R.; Morikawa, A.; Zaitsu, K. Sensitive determination of D-amino acids in mammals and the effect of D-aminoacid oxidase activity on their amounts. Biol. Pharm. Bull., 2005, 28, 1578-84.
38. Foltyn, V.N.; Bendikov, I.; De Miranda, J.; Panizzutti, R.; Dumin, E.; Shleper, M.; Li, P.; Toney, M.D.; Kartvelishvily, E.; Wolosker, H. Serine racemase modulates intracellular D-serine levels through an alpha, beta-elimination activity. J. Biol. Chem., 2005, 280, 1754-63.
39. Shoji, K.; Mariotto, S.; Ciampa, A.R.; Suzuki, H. Regulation of serine racemase activity by D-serine and nitric oxide in human glioblastoma cells. Neurosci. Lett., 2006, 392, 75-8.
40. Shoji, K.; Mariotto, S.; Ciampa, A.R.; Suzuki, H. Mutual regulation between serine and nitric oxide metabolism in human glioblastoma cells. Neurosci. Lett., 2006, 394, 163-7.
41. Mustafa, A.K.; Kumar, M.; Selvakumar, B.; Ho, G.P.H.; Ehmsen, J.T.; Barrow, R.K.; Amzel, L.M.; Snyder, S.H. Nitric oxide Snitrosylates serine racemase, mediating feedback inhibition of Dserine formation. Proc. Natl. Acad. Sci. U.S.A., 2007, 104, 2950-5.
42. Bliss, T.V.; Collingridge, G.L. A synaptic model of memory: longterm potentiation in the hippocampus. Nature, 1993, 361, 31-9.
43. Palazzo, E.; de Novellis, V.; Marabese, I.; Cuomo, D.; Rossi, F.; Maione, S. Interaction between vanilloid and glutamate receptors in the central modulation of nociception. Eur. J. Pharmacol., 2002, 439, 69-75.
44. Wang, C.; McInnis, J.; Ross-Sanchez, M.; Shinnick-Gallagher, P.; Wiley, J.L.; Johnson, K.M. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience, 2001, 107, 535-50.
45. Meldrum, B.S.; Akbar, M.T.; Chapman, A.G. Glutamate receptors and transporters in genetic and acquired models of epilepsy. Epilepsy Res., 1999, 36, 189-204.
46. Danysz, W.; Parsons, A.C. Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol. Rev., 1998, 50, 597-664.
47. Matsui, T.; Sekiguchi, M.; Hashimoto, A.; Tomita, U.; Nishikawa, T.; Wada, K. Functional comparison of D-serine and glycine in rodents: the effect on Cloned NMDA receptors and the extracellular concentration. J. Neurochem., 1995, 65, 454-8.
48. Martina, M.; Krasteniakov, N.V.; Bergeron, R. D-serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons. J. Physiol., 2003, 548, 411-23.
49. Yang, C.R.; Svensson, K.A. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia. Pharmacol. Ther., 2008, 120, 317-32.
50. Yang, Y.; Ge, W.; Chen, Y.; Zhang, Z.; Shen, W.; Wu, C.; Poo, M.; Duan, S. Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine. Proc. Natl. Acad. Sci. U.S.A., 2003, 100, 15194-9.
51. Maekawa, M.; Watanabe, M.; Yamaguchi, S.; Konno, R.; Hori, Y. Spatial learning and long-term potentiation of mutant mice lacking D-amino-acid oxidase. Neurosci. Res., 2005, 53, 34-8.
52. Mothet, J.P.; Rouaud, E.; Sinet, P.M.; Potier, B.; Jouvenceau, A.; Dutar, P.; Videau, C.; Epelbaum, J.; Billard, J.M. A critical role for the glial-derived neuromodulator D-serine in the age-related deficits of cellular mechanisms of learning and memory. Aging Cell, 2006, 5, 267-74.
53. Shleper, M.; Kartvelishvily, E.; Wolosker, H. D-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices. J. Neurosci., 2005, 25, 9413-7.
54. Duffy, S.; Labrie, V.; Roder, J.C. D-serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning. Neuropsychopharmacology, 2008, 33, 1004-18.
55. Kolhekar, R.; Meller, S.T.; Gebhart, G.F. N-methyl-D-aspartate receptor-mediated changes in thermal nociception: allosteric modulation at glycine and polyamine recognition sites. Neuroscience, 1994, 63, 925-36.
56. Zhang, Y.H.; Shu, Y.S.; Zhao, Z.Q. Substance P potentiates thermal hyperalgesia induced by intrathecal administration of D-serine in rats. Acta Pharmacol. Sin., 2001, 22, 817-20.
57. Ahmadi, S.; Muth-Selbach, U.; Lauterbach, A.; Lipfert, P.; Neuhuber, W.L.; Zeilhofer, H.U. Facilitation of spinal NMDA receptor currents by spillover of synaptically released glycine. Science, 2003, 300, 2094-7.
58. Muth-Selbach, U.; Dybek, E.; Kollosche, K.; Stegmann, JU.; Holthusen, H.; Lipfert, P.; Zeilhofer, HU. The spinal antinociceptive effect of nocistatin in neuropathic rats is blocked by D-serine. Anesthesiology, 2004, 101, 753-8.
59. Wake, K.; Yamazaki, H.; Hanzawa, S.; Konno, R.; Sakio, H.; Niwa, A.; Hori, Y. Exaggerated responses to chronic nociceptive stimuli and enhancement of N-methyl-D-aspartate receptormediated synaptic transmission in mutant mice lacking D-aminoacid oxidase. Neurosci. Lett., 2001, 297, 25-8.
60. Hashimoto, K.; Engberg, G.; Shimizu, E.; Nordin, C.; Lindstrom, L.H.; Iyo, M. Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2005, 29, 767-9.
61. Bendikov, I.; Nadri, C.; Amar, S.; Panizzutti, R.; De Miranda, J.; Wolosker, H.; Agam, G. A CSF and postmortem brain study of Dserine metabolic parameters in schizophrenia. Schizophr. Res., 2007, 90, 41-51.
62. Verrall, L.; Walker, M.; Rawlings, N.; Benzel, I.; Kew, J.N.; Harrison, P.J.; Burnet, P.W. D-amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia. Eur. J. Neurosci., 2007, 26, 1657-69.
63. Steffek, A.E.; Haroutunian, V.; Meador-Woodruff, J.H. Serine racemase protein expression in cortex and hippocampus in schizophrenia. Neuroreport, 2006, 17, 1181-5.
64. Fisher, G.; Lorenzo, N.; Abe, H.; Fujita, E.; Frey, W.H.; Emory, C.; Di Fiore, M.M.; D'Aniello, A. Free D- and L-amino acids in ventricular cerebrospinal fluid from Alzheimer and normal subjects. Amino Acids, 1998, 15, 263-9.
65. Schwartz, B.L.; Hashtroudi, S.; Herting, R.L.; Schwartz, P.; Deutsch, S.I. D-cycloserine enhances implicit memory in Alzheimer patients. Neurology, 1996, 46, 420-4.
66. Tsai, G.; Falk, W.E.; Gunther, J.; Coyle, J.T. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. Am. J. Psychiatr., 1999, 156, 467-9.
67. Hashimoto, K.; Fukushima, T.; Shimizu, E.; Okada, S.; Komatsu, N.; Okamura, N.; Koike, K.; Koizumi, H.; Kumakiri, C.; Imai, K.; Iyo, M. Possible role of D-serine in the pathophysiology of Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2004, 28, 385-8.
68. Tsai, G.; Yang, P.; Chung, L.C.; Lange, N.; Coyle, J.T. D-serine added to antipsychotics for the treatment of schizophrenia. Biol. Psychiatry, 1998, 44, 1081-9.
69. Javitt D.C. Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients. Curr. Opin. Psychiatry, 2006, 19, 151-7.
70. Buchanan, R.W.; Javitt, D.C.; Marder, S.R.; Schooler, N.R.; Gold, J.M.; McMahon, R.P.; Heresco-Levy, U.; Carpenter, W.T. The Cognitive and negative symptoms in schizophrenia trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am. J. Psychiatry, 2007, 164, 1593-602.
71. Ogawa, M.; Shigeto, H.; Yamamoto, T.; Oya, Y.; Wada, K.; Nishikawa, T.; Kawai, M. D-cycloserine for the treatment of ataxia in spinocerebellar degeneration. J. Neurol. Sci., 2003, 210, 53-6.
72. Furukawa, H.; Gouaux, E. Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core. EMBO J., 2003, 22, 2873-85.
73. Hashimoto, A.; Yoshikawa, M. Effect of aminooxyacetic acid on extracellular level of D-serine in rat striatum: an in vivo microdialysis study. Eur. J. Pharmacol., 2005, 525, 91-3.
74. Kanematsu, S.; Ishi, S.; Umino, A.; Fujihira, T.; Kashiwa, A.; Yamamoto, N.; Kurumaji, A.; Nishikawa, T. Evidence for involvement of glial cell activity in the control of extracellular D-serine contents in the rat brain. J. Neural. Transm., 2006, 113, 1717-21.
75. Shim, S.S.; Hammonds, M.D.; Kee, B.S. Potentiation of the NMDA receptor in the treatment of schizophrenia: focus on the glycine site. Eur. Arch. Psychiatry Clin. Neurosci., 2008, 258, 16-27.
76. Karasawa, J.; Hashimoto, K.; Chaki, S. D-serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Behav. Brain Res., 2008, 186, 78-83.
77. Boks, M.P.; Rietkerk, T.; van de Beek, M.H.; Sommer, I.E.; de Koning, T.J.; Kahn, R.S. Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia. Eur. Neuropsychopharmacol., 2007, 17, 567-72.
78. Adage, T.; Trillat, A.; Quattropani, A.; Perrin, D.; Cavarec, L.; Shaw, J.; Guerassimenko, O.; Giachetti, C.; Greco, B.; Chumakov, I.; Halazy, S.; Roach, A.; Zaratin, P. In vitro and in vivo pharmacological profile of AS057278, a selective D-amino acid oxidase inhibitor with potential anti-psychotic properties. Eur. Neuropsychopharmacol., 2008, 18, 200-12.
79. Ferraris, D.; Duvall, B.; Ko, Y.S.; Thomas, A.G.; Rojas, C.; Majer, P.; Hashimoto, K.; Tsukamoto, T.J. Synthesis and biological evaluation of D-amino acid oxidase inhibitors. Med. Chem., 2008, 51, 3357-9.
80. Fuchs, S.A.; Dorland, L.; de Sain-van der Velden, M.G.; Hendriks, M.; Klomp, L.W.J.; Berger, R.; de Koning, T.J. D-serine in the developing human central nervous system. Ann. Neurol., 2006, 60, 476-80.
81. Sasabe, J.; Chiba, T.; Yamada, M.; Okamoto, K.; Nishimoto, I.; Matsuoka, M.; Aiso, S. D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis. EMBO J., 2007, 26, 4149-59.
82. Detera-Wadleigh, S.D.; McMahon, F.J. G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol. Psychiatry, 2006, 60, 106-14.
83. Santos, P.; Bittencourt, A.S.; Schenberg, L.C.; Carobrez, A.P. Elevated T-maze evaluation of anxiety and memory effects of NMDA/glycine-B site ligands injected into the dorsal periaqueductal gray matter and the superior colliculus of rats. Neuropharmacology, 2006, 51, 203-12.
84. Javitt, D.C. Glutamate as a therapeutic target in psychiatric disorders. Mol. Psychiatry, 2004, 9, 984-97.
85. Yang, S.; Qiao, H.; Wen, L.; Zhou, W.; Zhang, Y. D-serine enhances impaired long-term potentiation in CA1 subfield of hippocampal slices from aged senescence-accelerated mouse prone/8. Neurosci. Lett., 2005, 379, 7-12.